This content is from: Trademarks

Crunching the numbers: trademark activity during COVID-19

Robert Reading, director of professional services and strategy at CompuMark (part of Clarivate), looks at COVID-19’s impact on pharmaceutical and medical trademark activity – and reveals some surprising findings

To access our in-house intelligence please request a trial here.

Read this article – and more – for a one-week period.


Are you already an Managing IP subscriber? Login here


Instant access to all of our content. Membership Options | One Week Trial